Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer.
Phase of Trial: Phase II/III
Latest Information Update: 09 Sep 2016
At a glance
- Drugs Paclitaxel (Primary) ; Bleomycin; Cisplatin; Etoposide
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 29 Apr 2014 Data cleaning project 4: Deleted descriptor - Filgrastim (concomitant medicaton).
- 23 Jan 2012 Results published in the Journal of Clinical Oncology.
- 22 Jun 2011 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History